Are there areas of IR that you feel deserve more attention in the 2027 programme, including topics from your own clinical practice?
Krokidis: I think the whole programme is very fascinating. However, for 2027, we have enhanced the dialysis intervention programme, which is a continuously evolving field, as well as stroke thrombectomy, where we believe body IRs may play a crucial role in the immediate future. The arterial programme is particularly strong, covering areas such as desert foot and some fascinating drug-related debates, while the venous track brings in the latest evidence on venous intervention.
Embolization, including emergency procedures, is again very well represented. Interventional oncology has been expanded to include topics like uveal melanoma. Pain management, another growing area for IRs, will receive greater attention. For those interested in offering the service, paediatric sessions have been added, and, as every year, there is a very interesting IR management programme.
Which sessions stood out to you at CIRSE 2026? Is there anything that you would like to build on for 2027?
Krokidis: We had very good feedback on the Beyond the Lecture sessions, which were newly introduced in 2026. The format offers the possibility of discussion and interaction between the speakers and the audience. In my view, this will be a popular format for future congresses.
You strongly believe in supporting younger doctors and strengthening the clinical role of IR. How would you like the 2027 programme to support these goals?
Krokidis: We have a very strong European Trainee Forum (ETF) programme where younger colleagues have the opportunity to present and interact. We also have a very strong student programme that has enjoyed great success in previous years, and we will continue with that direction for 2027.